Evidence map›Paper›PMID 25240082›Full record

ArticleThe American journal of clinical nutrition2014

Zinc deficiency in children with environmental enteropathy-development of new strategies: report from an expert workshop.

Graeme P Young, Elissa K Mortimer, Geetha L Gopalsamy, David H Alpers, Henry J Binder, Mark J Manary, Balakrishnan S Ramakrishna, Ian L Brown, Thomas G Brewer

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of clinical nutrition, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

Graeme P YoungFrom the School of Medicine, Flinders University of South Australia, Adelaide, Australia (GPY, EKM, GLG, and ILB); Washington University School of Medicine, St Louis, MO (DHA and MJM); Yale University School of Medicine, New Haven, CT (HJB); the Department of Medical Gastroenterology, Christian Medical College Vellore, Vellore, India (BSR); and Enteric and Diarrheal Diseases, the Bill & Melinda Gates Foundation, Seattle, WA (TGB).
Elissa K MortimerFrom the School of Medicine, Flinders University of South Australia, Adelaide, Australia (GPY, EKM, GLG, and ILB); Washington University School of Medicine, St Louis, MO (DHA and MJM); Yale University School of Medicine, New Haven, CT (HJB); the Department of Medical Gastroenterology, Christian Medical College Vellore, Vellore, India (BSR); and Enteric and Diarrheal Diseases, the Bill & Melinda Gates Foundation, Seattle, WA (TGB).
Geetha L GopalsamyFrom the School of Medicine, Flinders University of South Australia, Adelaide, Australia (GPY, EKM, GLG, and ILB); Washington University School of Medicine, St Louis, MO (DHA and MJM); Yale University School of Medicine, New Haven, CT (HJB); the Department of Medical Gastroenterology, Christian Medical College Vellore, Vellore, India (BSR); and Enteric and Diarrheal Diseases, the Bill & Melinda Gates Foundation, Seattle, WA (TGB).
David H AlpersFrom the School of Medicine, Flinders University of South Australia, Adelaide, Australia (GPY, EKM, GLG, and ILB); Washington University School of Medicine, St Louis, MO (DHA and MJM); Yale University School of Medicine, New Haven, CT (HJB); the Department of Medical Gastroenterology, Christian Medical College Vellore, Vellore, India (BSR); and Enteric and Diarrheal Diseases, the Bill & Melinda Gates Foundation, Seattle, WA (TGB).
Henry J BinderFrom the School of Medicine, Flinders University of South Australia, Adelaide, Australia (GPY, EKM, GLG, and ILB); Washington University School of Medicine, St Louis, MO (DHA and MJM); Yale University School of Medicine, New Haven, CT (HJB); the Department of Medical Gastroenterology, Christian Medical College Vellore, Vellore, India (BSR); and Enteric and Diarrheal Diseases, the Bill & Melinda Gates Foundation, Seattle, WA (TGB).
Mark J ManaryFrom the School of Medicine, Flinders University of South Australia, Adelaide, Australia (GPY, EKM, GLG, and ILB); Washington University School of Medicine, St Louis, MO (DHA and MJM); Yale University School of Medicine, New Haven, CT (HJB); the Department of Medical Gastroenterology, Christian Medical College Vellore, Vellore, India (BSR); and Enteric and Diarrheal Diseases, the Bill & Melinda Gates Foundation, Seattle, WA (TGB).
Balakrishnan S RamakrishnaFrom the School of Medicine, Flinders University of South Australia, Adelaide, Australia (GPY, EKM, GLG, and ILB); Washington University School of Medicine, St Louis, MO (DHA and MJM); Yale University School of Medicine, New Haven, CT (HJB); the Department of Medical Gastroenterology, Christian Medical College Vellore, Vellore, India (BSR); and Enteric and Diarrheal Diseases, the Bill & Melinda Gates Foundation, Seattle, WA (TGB).
Ian L BrownFrom the School of Medicine, Flinders University of South Australia, Adelaide, Australia (GPY, EKM, GLG, and ILB); Washington University School of Medicine, St Louis, MO (DHA and MJM); Yale University School of Medicine, New Haven, CT (HJB); the Department of Medical Gastroenterology, Christian Medical College Vellore, Vellore, India (BSR); and Enteric and Diarrheal Diseases, the Bill & Melinda Gates Foundation, Seattle, WA (TGB).
Thomas G BrewerFrom the School of Medicine, Flinders University of South Australia, Adelaide, Australia (GPY, EKM, GLG, and ILB); Washington University School of Medicine, St Louis, MO (DHA and MJM); Yale University School of Medicine, New Haven, CT (HJB); the Department of Medical Gastroenterology, Christian Medical College Vellore, Vellore, India (BSR); and Enteric and Diarrheal Diseases, the Bill & Melinda Gates Foundation, Seattle, WA (TGB).
Flinders University · AUGates Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zinc deficiency is a major cause of childhood morbidity and mortality. The WHO/UNICEF strategy for zinc supplementation as adjunctive therapy for diarrhea is poorly implemented. A conference of experts in zinc nutrition and gastrointestinal disorders was convened to consider approaches that might complement the current recommendation and what research was needed to develop these approaches. Several key points were identified. The design of novel zinc interventions would be facilitated by a better understanding of how disturbed gut function, such as environmental (or tropical) enteropathy, affects zinc absorption, losses, and homeostasis. Because only 10% of zinc stores are able to be rapidly turned over, and appear to be rapidly depleted by acute intestinal illness, they are probably best maintained by complementary regular supplementation in a primary prevention strategy rather than secondary prevention triggered by acute diarrhea. The assessment of zinc status is challenging and complex without simple, validated measures to facilitate field testing of novel interventions. Zinc bioavailability may be a crucial factor in the success of primary prevention strategies, and a range of options, all still inadequately explored, might be valuable in improving zinc nutrition. Some therapeutic actions of zinc on diarrhea seem attributable to pharmacologic effects, whereas others are related to the reversal of deficiency (ie, nutritional). The distinction between these 2 mechanisms cannot be clarified given the insensitivity of serum zinc to identify subclinical deficiency states. Why zinc seems to be less effective than expected at all ages, and ineffective for secondary prevention of diarrhea in children <12 mo of age, remains unclear. It was concluded that a reframing of the current recommendation is warranted with consideration of how to better optimize and deliver zinc and whether to provide a complementary public health primary prevention zinc strategy. This requires careful consideration of the zinc product to be used as well as strategies for its delivery.

Indexed as

Dietary SupplementsBiological AvailabilityChildChild, PreschoolDiarrheaFemaleHomeostasisHumansIntestinesMaleMorbidityNutritional StatusNutrition AssessmentRecommended Dietary AllowancesWorld Health OrganizationZincZinc

Identifiers

PMID25240082
PMCPMC4163797
OpenAlexW2146578656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.